HBV DNA DETECTION BY REAL TIME PCR (QUALITATIVE)

The HBV DNA Detection by Real Time PCR (Qualitative) test uses sensitive molecular amplification to determine the presence or absence of hepatitis B virus genetic material in a patient sample. Unlike serology, which detects antigens or antibodies, this qualitative PCR directly identifies viral DNA and is valuable for confirming active HBV infection or occult infection when serologic results are unclear. Performed using real‑time PCR technology, the assay provides reliable detection with high analytical sensitivity, supporting early diagnosis and appropriate clinical decision‑making.

This test is recommended for individuals with suspected acute or chronic hepatitis B, patients with positive or equivocal HBsAg/anti‑HBs/anti‑HBc serology, and persons who are immunocompromised or about to undergo immunosuppressive therapy or organ transplantation. It is also useful for screening newborns of HBV‑positive mothers and for initial confirmation before ordering quantitative viral load testing for treatment monitoring. Touch Connect offers convenient at‑home sample collection across Dubai and the UAE, with results delivered to your registered clinician to support timely follow‑up and management.

• HBV DNA (Qualitative)
• Detection Status (Detected / Not Detected)
• Analytical Method: Real‑time PCR
• Sample Type: Plasma / EDTA whole blood

• Suspected acute hepatitis B with clinical symptoms (jaundice, malaise)
• Confirm active infection when HBsAg or anti‑HBc results are positive or indeterminate
• Assessment before starting immunosuppressive therapy or chemotherapy
• Screening newborns born to HBV‑positive mothers
• Evaluation in immunocompromised patients or those with unexplained liver enzyme elevation

• High sensitivity detection of viral DNA for early or occult infection
• Direct confirmation of active HBV replication (qualitative) to guide next steps
• Convenient licensed at‑home sample collection across Dubai and the UAE
• Fast, laboratory‑grade results suitable for clinician follow‑up
• Supports appropriate referral for quantitative viral load testing and treatment decisions

• At‑home venous blood collection by a licensed phlebotomist (EDTA tube preferred)
• No fasting required; stay hydrated before collection
• Inform the phlebotomist/clinician of any current or recent antiviral therapy (may affect detection)
• Provide prior HBV serology results (HBsAg, anti‑HBs, anti‑HBc) if available